title: Ingestion of eicosapentaenoic acid in the early stage of social isolation reduces a fibroblast growth factor 21 resistant state independently of body weight in KKA(y) mice.
abstract: Fibroblast growth factor (FGF) 21 is a mediator of glucose and lipid metabolism. Although exogenous administration of FGF21 exerts beneficial effects on glucose and lipid metabolism, circulating FGF21 levels are elevated in ob/ob and db/db mice, diet-induced obese mice and obese human. Here we show that ingestion of eicosapentaenoic acid (EPA) for 6 days after individually-housing significantly suppressed the hyperglycemia and hypertriglyceridemia associated with decreases in plasma insulin and FGF21 levels in KKA(y) mice while having no effects on food intake, body weight or plasma active GLP-1 levels. The ingestion of EPA had no significant effects on the expression of FGF21 in the liver, epididymal white adipose tissue and skeletal muscle. Moreover, the ingestion of EPA significantly decreased the expression of hepatic peroxisome sterol regulatory element-binding protein (SREBP1c), carbohydrate response element-binding protein (ChREBP), stearoyl-CoA deaturase and periostin, which are involved in hepatic lipogenesis and hepatosteaotosis, in KKA(y) mice. On the other hand, the ingestion of EPA had no significant effects on expression of hepatic gp78, Notch, forkhead box protein O1 or glucose-6-phosphatase. These findings suggest that EPA ingestion in the early stage of social isolation suppresses hyperglycemia and hypertriglyceridemia associated with reduced FGF21 and insulin resistance without altering food intake and body weight, and that the EPA ingestion suppresses hepatic lipogenesis by suppressing Notch- and gp78-independent SEREBP1c and ChREBP pathways in KKA(y) mice.
authors.affiliation: Department of Diabetes Technology, Tohoku University, Graduate School of Biomedical Engineering, 6-6-11 Aramakiaza-Aoba, Aoba-ku, Sendai, Miyagi, 980-8579, Japan. Electronic address: katsu@trc.med.tohoku.ac.jp.
authors.forename: Katsunori
authors.initials: K
authors.lastname: Nonogaki
authors.affiliation: Department of Diabetes Technology, Tohoku University, Graduate School of Biomedical Engineering, 6-6-11 Aramakiaza-Aoba, Aoba-ku, Sendai, Miyagi, 980-8579, Japan.
authors.forename: Tomoe
authors.initials: T
authors.lastname: Yamazaki
authors.affiliation: Department of Diabetes Technology, Tohoku University, Graduate School of Biomedical Engineering, 6-6-11 Aramakiaza-Aoba, Aoba-ku, Sendai, Miyagi, 980-8579, Japan.
authors.forename: Mari
authors.initials: M
authors.lastname: Murakami
authors.affiliation: Department of Diabetes Technology, Tohoku University, Graduate School of Biomedical Engineering, 6-6-11 Aramakiaza-Aoba, Aoba-ku, Sendai, Miyagi, 980-8579, Japan.
authors.forename: Takao
authors.initials: T
authors.lastname: Kaji
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage* / Q000494:pharmacology; D005247:Feeding Behavior / Q000187:drug effects; D005346:Fibroblast Growth Factors / Q000097:blood / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects; D052216:Glucagon-Like Peptide 1 / Q000097:blood; D007328:Insulin / Q000097:blood; D008297:Male; D051379:Mice; D012934:Social Isolation; D014280:Triglycerides / Q000097:blood
chemical_list: D001786:Blood Glucose; D007328:Insulin; D014280:Triglycerides; C414620:fibroblast growth factor 21; D005346:Fibroblast Growth Factors; D052216:Glucagon-Like Peptide 1; D015118:Eicosapentaenoic Acid
keywords: ChREBP; EPA; FGF21; GLP-1; Hyperglycemia; Hypertriglyceridemia; Lipogenesis; Notch; Periostin; SREBP1c; gp78